Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al.

Science. 1994 Oct 7;266(5182):66-71.

PMID:
7545954
2.

BRCA1 mutations in primary breast and ovarian carcinomas.

Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al.

Science. 1994 Oct 7;266(5182):120-2.

PMID:
7939630
3.

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.

Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc JF, Bélanger C, Dion F, et al.

Nat Genet. 1994 Dec;8(4):392-8.

PMID:
7894492
4.

Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, Collins FS, Tucker MA.

Am J Hum Genet. 1995 Jul;57(1):1-7.

5.

BRCA1 and prostate cancer.

Rosen EM, Fan S, Goldberg ID.

Cancer Invest. 2001;19(4):396-412. Review.

PMID:
11405179
6.

Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.

Rutter JL, Smith AM, Dávila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP.

Hum Mutat. 2003 Aug;22(2):121-8.

PMID:
12872252
7.

Mutations of the BRCA1 gene in human cancer.

Xu CF, Solomon E.

Semin Cancer Biol. 1996 Feb;7(1):33-40. Review.

PMID:
8695765
8.

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.

Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC.

Nat Genet. 1994 Dec;8(4):399-404.

PMID:
7894493
9.

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, et al.

Nat Genet. 1994 Dec;8(4):387-91.

PMID:
7894491
10.

Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.

Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS, et al.

Clin Cancer Res. 1995 May;1(5):539-44.

11.

Progress toward isolation of a breast cancer susceptibility gene, BRCA1.

Weber BL, Abel KJ, Couch FJ, Merajver SD, Chandrasekharappa SC, Castilla L, McKinley D, Ho PP, Calzone K, Frank TS, et al.

Cold Spring Harb Symp Quant Biol. 1994;59:531-6.

PMID:
7587109
12.

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA.

Am J Hum Genet. 1998 Nov;63(5):1341-51.

13.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

14.

Mutation analysis of the BRCA1 gene in ovarian cancers.

Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, LiVolsi VA, et al.

Cancer Res. 1995 Jul 15;55(14):2998-3002.

15.

Has the breast cancer gene been found?

Vogelstein B, Kinzler KW.

Cell. 1994 Oct 7;79(1):1-3. Review. No abstract available.

PMID:
7923368
16.

Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.

Couch FJ, Garber J, Kiousis S, Calzone K, Hauser ER, Merajver SD, Frank TS, Boehnke M, Chamberlain JS, Collins FS, et al.

J Natl Cancer Inst Monogr. 1995;(17):9-14.

PMID:
8573462
17.

Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.

Steichen-Gersdorf E, Gallion HH, Ford D, Girodet C, Easton DF, DiCioccio RA, Evans G, Ponder MA, Pye C, Mazoyer S, et al.

Am J Hum Genet. 1994 Nov;55(5):870-5.

18.

A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.

Tangir J, Muto MG, Berkowitz RS, Welch WR, Bell DA, Mok SC.

Oncogene. 1996 Feb 15;12(4):735-40.

PMID:
8632895
19.

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA.

Nat Genet. 1996 Mar;12(3):309-11.

PMID:
8589723
20.

Linkage analysis of BRCA1 in Japanese breast cancer families.

Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M.

Jpn J Cancer Res. 1994 Dec;85(12):1233-9.

PMID:
7852187

Supplemental Content

Support Center